Abstract-In this paper, we will propose a density estimation based data analysis procedure to investigate the co-morbid associations between migraine and the suspected diseases. The primary objective of this study has aimed to develop a novel analysis procedure that can discover insightful knowledge from large medical databases. The entire analysis procedure consists of two stages. During the first stage, a kernel density estimation algorithm named RVKDE is invoked to identify the samples of interest. Then, in the second stage, a density estimation algorithm based on generalized Gaussian components and named G 2 DE is invoked to provide a summarized description of the distribution. The results obtained by applying the proposed two-staged procedure to analyze co-morbidities of migraine reveal that the proposed procedure can effectively identify a number of clusters of samples with distinctive characteristics. Furthermore, it has been observed that the distinctive characteristics of the clusters are in conformity with recently discovered knowledge in biomedical research. Accordingly, it is conceivable that the proposed analysis procedure will be exploited to provide valuable clues of pathogenesis and facilitate development of proper treatment strategies.
INTRODUCTION
In recent years, data analysis based on large medical and clinical databases has gained attention among biomedical researchers [1] [2] [3] . One major merit of this type of studies is that these databases collect cases with good demographic diversity. In addition, researchers can expeditiously test their hypotheses since they do not need to spend a significant amount of efforts to recruit cases. Nevertheless, most studies have been conducted with conventional biostatistical approaches. Accordingly, scientists have turned to exploit advanced machine learning and/or data mining approaches to extract valuable clues hidden in large medical and clinical databases [3] [4] [5] [6] . For example, the Bayesian network has been exploited to identify the co-morbidity between chronic obstructive pulmonary disease and asthma [3] .
In this article, we will propose exploiting two density estimation algorithms in analysis of co-morbidity. The two density estimation algorithms were named RVKDE (Relaxed Variable Kernel Density Estimation) [7] and G 2 DE (Generalized Gaussian component based Density Estimation) [8] , respectively. The RVKDE algorithm has been exploited to identify samples of interest. In the meantime, the G 2 DE algorithm has been exploited to provide a summarized description of the distribution.
In our study, we have applied the proposed approach to analyze co-morbidity of migraine. Migraine is a prevalent neurological disorder whereby patients suffer from recurrent headache attacks, nausea, photophobia, and phonophobia. This neurological disorder is more common to women than to men, and its burden is underestimated. Many illnesses, physical or psychiatric, are reported to be co-morbid with migraine [9] [10] [11] [12] [13] [14] ; these disorders occur at a greater coincidental rate than what is seen in the general population. Understanding the association of migraine with other health conditions can help the clinicians providing better care and investigate the pathogenesis of these disorders.
II. METHODS

A. Density Estimation Algorithms
Density estimation is a classic research issue in statistics [15] . The problem definition of density estimation is to obtain an approximate probability density function based on a given set of random samples. In recent years, we have been designing density estimation algorithms for bioinformatics applications [16] [17] [18] . In our study reported in this article, we have exploited two recently proposed density estimation algorithms, namely, the RVKDE algorithm and the G 2 DE algorithm. The RVKDE algorithm has been exploited to identify samples of interest. In the meantime, the G space. Then, with the RVKDE algorithm, a kernel density estimator, which is actually an approximate probability density function, fˆis constructed as follows:
fˆ, the dimension of the vector space that the G 2 DE algorithm can actually handle may be limited due to the effectiveness of the optimization algorithm. The reality is that even the most advanced optimization algorithm can hardly handle a highly rugged function with more than 50 variables. Accordingly, in our approach proposed in this article, the G 2 DE algorithm is only incorporated in the second stage of the analysis procedure to provide a summarized description of the underlying distribution.
B. The Clinical Database
The study reported in this article has been conducted based on the Research Database released by the National Health Insurance Program in Taiwan. The National Health Insurance (NHI) program in Taiwan was launched in 1995 and as in December 2010 covered 23,074,487 insurants, which account for over 99% of the entire population in Taiwan. Furthermore, almost all medical hospitals and clinics in Taiwan have joined the program. As in December 2010, there were 25,031 medical institutes enrolled in the program. Since 2000, the Bureau of the program began to release the National Health Insurance Research Database (NHIRD) to facilitate medical research. The updated version used in this study contains the ambulatory and hospitalization claims records of 1,000,000 randomly selected insurants over the period from 1996 to 2007 without significant difference in age, sex, and insurance cost relative to the whole population.
C. Case Patient Definition and Control Selection
The cases in this study contained patients who were diagnosed with migraine two or more times during 2000 to 2007. The ICD-9 CM codes (International Classification of Disease, 9
th Revision, Clinical Modification) [20] used for classification include 346.0x, 346.1x, and 346.9x, corresponding to subjects of migraine with or without aura. In this case-control study, for each migraine case five insurants without any migraine record during 2000 to 2007 and matching the gender and age of the corresponding case were randomly selected from the NHIRD. As a result, the cohort contains 8,746 migraine cases and 43,730 controls. For each case, the date of the first migraine diagnosis is defined to be the index date, and matched controls are assigned the same index date.
D. Disease Utilized as Features
In this research, eighteen diseases that have been identified as co-morbidities of migraine in previous studies [9] [10] [11] [12] [13] [14] are included in the feature set. These diseases can be classified into five categories and the ICD-9 CM codes used to identify the patients of these diseases are as follows:
1. It must be noted that for diagnoses for psychiatric disorders we only included those issued by psychiatrists in order to eliminate false diagnoses.
In our dataset, the event date of an insurant with respect to a specific disease is defined to be the date of his/her first diagnosis. On the other hand, if an insurant never suffered a specific disease during the study period, then the event date the insurant with respect to the disease is defined to be December 31 of 2007, which is the last day of the study period. In our study, demographics and clinical variables were compared between migraine cases and controls using the chi-square test or student T-test when appropriate. We have employed the odds ratio (OR) with 95% confidence interval to quantify the risk of a comorbidity of migraine in different groups of patients. All tests were two-tailed, and p values < 0.05 were considered significant.
E. The Analysis Procedure
The dataset consists of two classes of samples, namely cases and controls, extracted from the HNIRD. Each sample is associated with an 18-dimension feature vector and each dimension corresponds to a possible comorbidity of migraine. Each value in the feature vector denotes to the difference between the migraine index date and the corresponding co-morbidity event date in number of days. If the corresponding co-morbidity was initially diagnosed before the migraine index date, then the feature value is positive, otherwise it is negative. If the sample did not suffer the corresponding co-morbidity at all, then the feature value is set to -10000, of which the absolute value is significantly larger than the possible meaningful value.
The analysis procedure consists of two stages. During the first stage, the RVKDE algorithm is invoked to constructed one approximate probability density function, denoted by fˆ , for the cases and another one, denoted by f ′ , for the controls. Let i s denote the feature vector corresponding to the i-th case in the dataset. Then, if
is greater than a threshold, the case is said to be of interest. This screening process aims to identify those cases that are distinctive from the controls with respect to some feature values. At the end of the first stage of the analysis procedure, all cases of interest are collected and submitted to the second stage for further analysis.
During the second stage of the analysis procedure, the G 2 DE algorithm is invoked to identify the major clusters of the cases of interest and provide a summarized description of the underlying distribution. However, as mentioned earlier, due to the nature of the optimization problem, the number of features that the G 2 DE algorithm can effectively handle is limited. Accordingly, the proposed analysis procedure incorporates a factor analysis step aimed to identify the most significant features before invoking the
The factor analysis step proceeds as follows. First, the correlation matrix of the original eighteen features is derived based on the cases of intereset identified in the first stage of analysis. Then, those eigenvectors with the corresponding eigenvalue larger than 1 are selected to form the factor space. Finally, the factor space is rotated orthogonally and the component features of the rotated factors with a loading larger than 0.4 are selected to form a subspace into which the original dataset is projected.
III. RESULTS Table I shows the demographics of the entire dataset, which includes 8,746 migraine cases and 43,730 controls. As expected, the distributions of ages and genders are identical among migraine cases and controls. During the first stage of the proposed analysis procedure, 4,128 migraine patients were identified as cases of interest. Table III shows the relative risks of comorbidities among these migraine cases of interest and the controls. If we compare the data in Table II and Table  III , we can conclude that these cases of interest suffered even higher risks of co-morbidities.
According to the demographics shown in Table IV , the 4,128 cases of interest and the remaining 4,618 migraine cases have almost identical gender distributions. However, the mean age of the cases of interest is older than the mean age of the remaining migraine cases, 45.6 vs. 41.0 with p-value<0.001. Table V shows the relative risks of co-morbidities among the cases of interest and the remaining migraine cases. Since Tables III and V confirm that the first stage of the proposed analysis procedure successfully identified a subset of migraine cases that suffered higher risks of developing co-morbidities, it is highly desirable to conduct an in-depth analysis. Accordingly, in the second stage of the proposed analysis procedure, the G 2 DE algorithm was invoked to identify the main clusters among the 4,128 cases of interest. As mentioned earlier, before invoking the G 2 DE algorithm, factor analysis was carried out to identify the most informative features. In this respect, it must be noted that the set of cases of interest passed the two criteria commonly adopted to measure the adequacy of applying factor analysis. In fact, applying the Kaiser-Meyer-Olkin (KMO) test on the set of cases of interest yielded a value of 0.684, which is higher than the commonly adopted threshold of 0.5, and applying the Bartlett's test yielded a value smaller than 0.001, which is significant for variance homogeneity. The end result of the factor analysis is that the following five diseases were selected: CAD, depression, neck sprain, allergic rhinitis, and epilepsy.
The G 2 DE algorithm identified 3 clusters with distinctive characteristics shown in Table VI . The cases in the second cluster is distinctive in that they did not suffer 
IV. DISCUSSIONS
A. Co-morbidities of Migraine
Our study confirms co-morbid relations between migraine and various diseases. In our study, the diseases included for co-morbidity analysis can be classified into five categories. Mental disorder: The correlation between mental disorder and migraine has been studied extensively in recent years and our results match the previous observations. The American Migraine Prevalence and Prevention (AMPP) study demonstrated that both depression and anxiety were included in the co-morbidity profiles of chronic migraine and episodic migraine patients [14] . Beghi et al using the Italian version of the Mini International Neuropsychiatry Interview (MINI) found that significant proportions of depression and moderate proportions of anxiety among migraine and tension-type headache patients [21] . Dilsaver et al showed the association between bipolar disorder and migraine [22] . In conformity with these studies, our results confirm that migraine patients are more likely than controls to suffer mental disorders. Shared serotonergic dysfunction between migraine and affective disorders may contribute these associations.
Allergic disease:
The association between migraine and asthma has still been under debate. The Head-HUNT study showed that both migraine and non-migrainous headache were more prevalent among those with asthma than those without [11] . On the contrary, another study showed that the risk of developing follow-up incident asthma was not materially higher for migraine patients [23] . Our results support the co-morbid associations between migraine and allergic rhinitis as well as asthma. Recent Evidence has suggested that activation and sensitization of primary afferent meningeal nociceptive neurons trigger migraine attacks and the triggering factor is the involvement of mast cells [24] . These findings may explain why allergic nasal symptoms accompany migraine.
Musculoskeletal illness: The Nord-Trondelag Health Survey found that prevalence of chronic headache was 4.6 times higher among individuals with musculoskeletal symptoms than among those without [10] . Similarly, 92 Israeli consecutive patients with migraine from a tertiary headache clinic suffered high incidence of fibromyalgia syndrome [25] . In addition, the National Health Examination and Nutrition Survey (NHANES) showed adults with headache/migraine suffered increased odds of rheumatoid arthritis [26] . Our results confirm the comorbid associations between migraine and various musculoskeletal illnesses.
Cardiovascular disease: For over one decade, it has been a consensus among biomedical scientists that migraine increases atherosclerosis risk and ignites cardiovascular disorders such as instance angina, ischemic heart disease, and stroke [12, 13, 27] . Schurks et al suggested that the MTHFR 677TT genotype magnifies risk of cardiovascular disease among migraine patients [28] . The work of Bigal and colleagues demonstrated a higher cardiovascular risk profile among migraine patients with higher cholesterol and blood pressure level [12] . In our population based study, all these cardiovascular illnesses were prevalent among migraine patients than among matched controls.
Miscellaneous: The co-morbidity between migraine and epilepsy has been confirmed in one recent Dutch study [29] . Furthermore, the linkage between epilepsy and visual aura migraine possibly results from a gene defect located at chromosome 9q21-q22 [30] . On the other hand, one recent study has concluded that kidney stone is a comorbidity of migraine [9] . Another study suggested that topiramate dosage, which is commonly used for migraine preventative treatment, was inversely correlated to urinary citrate excretion and leaded to increased risk of stoneforming [31] . Finally, it has been reported that patients with Meniere's disease suffered higher prevalence of migraine and Meniere's disease patients with migraine suffered more severe vertigo or hearing loss [32] . Again, the results from our population-based study are in conformity with these findings.
B. Analysis Results of Density Estimation
It is worth noting that the findings due to applying the proposed analysis procedure are in conformity with the newly discovered knowledge reported in latest medical articles. In particular, it has been reported that depressive symptoms predict musculoskeletal morbidities [33] and the cases in the first cluster identified by the G 2 DE algorithm simply suffered higher risks of depression and neck sprain. In addition, the enhanced influence of allergic diseases on cardiovascular disorders has been observed in the Bruneck and ARMY study [34] and the cases in the third cluster identified by the G 2 DE algorithm simply suffered higher risks of allergic rhinitis and CAD. With these observations, we can conclude that the proposed analysis procedure can successfully identify distinctive cases and provide valuable clues of pathogenesis, which then can facilitate development of proper treatment strategies. For example, it has been reported that the migraine patients with major depressive disorder had more somatic symptoms [35, 36] and tricyclic antidepressants and selective norepinephrine reuptake inhibitor were good choices of preventative treatment.
C. Limitations
A major strength of our study was utilization of a large population-based medical claims database, but there were some limitations. First, administrative claims reported by hospitals or clinics may be less accurate than clinical diagnoses and observer-rating scales. Furthermore, the prevalence of migraine in this cohort was 0.9%, which is much lower than the estimated prevalence in the community of 14.4% [37] . It may be many patients with migraine failed to seek medical help [38] . Second, the administrative claims data of NHIRD did not include detailed personal information like body mass index, living habits, or results of laboratory tests, which might be important confounding factors. Third, prescription of treatments for migraine or the associated co-morbidities considered should be taken into account for detailed analyses.
V. CONCLUSIONS
In recent years, data analysis based on large medical and clinical databases has gained attention among biomedical researchers. Furthermore, scientists have turned to exploit advanced machine learning and/or data mining approaches to extract valuable clues hidden in large medical and clinical databases. In this paper, we have proposed a density estimation based data analysis procedure to investigate the co-morbid associations between migraine and the suspected diseases. The primary objective of this study has aimed to develop a novel analysis procedure that can discover insightful knowledge from large medical databases. The results obtained by applying the proposed two-staged procedure to analyze comorbidities of migraine reveal that the proposed procedure can effectively identify a number of clusters of cases with distinctive characteristics. Furthermore, it has been observed that the distinctive characteristics of the clusters are in conformity with recently discovered knowledge in biomedical research. Accordingly, it is conceivable that the proposed analysis procedure will be exploited to provide valuable clues of pathogenesis and facilitate development of proper treatment strategies.
